The Patient Financial Services Department is seeking a Patient Authorization Specialist to work in collaboration with the MSK clinical and administrative staff, patients, and insurance carriers to ensure the optimal payment for the care we provide.
Manage the patient insurance authorization process required for services that are being requested by the clinical staff responsible for the patients care
Initiate communications with patients insurance carrier upon receiving information from the clinical team for services that require pre certification/authorization
Work proactively with insurance carriers to ensure that all of the required information for payment has been received in a timely fashion.
Communicate and advise the clinical team on any changes in insurance companiesreimbursement practices related to the authorization of process.
Maintain ongoing communication with the treating clinical team during the authorization process to provide timely updates on the outcomes of the requests for services from insurance carriers.
Educate and counsel patients on their insurance coverage and explain payment options that are available to them.
A Bachelor's degree preferred
Excellent written and verbal communication skills
Ability to work independently and capable of making decisions
Patient/customer service experience
Schedule: Monday-Friday (9am-5pm)
Internal Number: 2019-31409
About Memorial Sloan-Kettering Cancer Center
As one of the world's premier cancer centers, Memorial Sloan-Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan-Kettering has an impact on cancer treatment and the biomedical research agenda around the world.